Long Time No See! Revisiting Single-Vessel Revascularization: Importance of Robust Study Design and Database Utilization
Conflicts of Interest
References
- Yeap, G.; Ramphul, K.; Ahmed, J.M.; Shah, A.; Jeelani, S.; Sakthivel, H.; Dulay, M.S.; Shahid, F.; Ahmed, R. Characteristics and In-Hospital Outcomes of Single-Vessel Coronary Disease Intervention: A Propensity-Matched Analysis of the National Inpatient Sample Database 2016–2020. Hearts 2024, 5, 557–568. [Google Scholar] [CrossRef]
- Neumann, F.J.; Sousa-Uva, M.; Ahlsson, A.; Alfonso, F.; Banning, A.P.; Benedetto, U.; Byrne, R.A.; Collet, J.P.; Falk, V.; Head, S.J.; et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 2019, 40, 87–167. [Google Scholar] [CrossRef] [PubMed]
- Byrne, R.A.; Fremes, S.; Capodanno, D.; Czerny, M.; Doenst, T.; Emberson, J.R.; Falk, V.; Gaudino, M.; McMurray, J.J.; Mehran, R.; et al. 2022 joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI and CABG. Eur. Heart J. 2023, 44, 4310–4320. [Google Scholar] [CrossRef] [PubMed]
- Alkhouli, M.; Alqahtani, F.; Kalra, A.; Gafoor, S.; Alhajji, M.; Alreshidan, M.; Holmes, D.R.; Lerman, A. Trends in characteristics and outcomes of patients undergoing coronary revascularization in the United States, 2003–2016. JAMA Netw. Open 2020, 3, e1921326. [Google Scholar] [CrossRef] [PubMed]
- Nathan, A.; Hashemzadeh, M.; Movahed, M.R. Percutaneous coronary intervention of chronic total occlusion associated with higher inpatient mortality and complications compared with non-CTO lesions. Am. J. Med. 2023, 136, 994–999. [Google Scholar] [CrossRef] [PubMed]
- Mäkikallio, T.; Holm, N.R.; Lindsay, M.; Spence, M.S.; Erglis, A.; Menown, I.B.; Trovik, T.; Eskola, M.; Romppanen, H.; Kellerth, T.; et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): A prospective, randomised, open-label, non-inferiority trial. Lancet 2016, 388, 2743–2752. [Google Scholar] [CrossRef] [PubMed]
- Tsang, M.B.; Schwalm, J.D.; Gandhi, S.; Sibbald, M.G.; Gafni, A.; Mercuri, M.; Salehian, O.; Lamy, A.; Pericak, D.; Jolly, S.; et al. Comparison of Heart Team vs Interventional Cardiologist recommendations for the treatment of patients with multi-vessel coronary artery disease. JAMA Netw. Open 2020, 4, e2012749. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Nienaber, C.A.; Nienaber, S. Long Time No See! Revisiting Single-Vessel Revascularization: Importance of Robust Study Design and Database Utilization. Hearts 2024, 5, 569-571. https://doi.org/10.3390/hearts5040042
Nienaber CA, Nienaber S. Long Time No See! Revisiting Single-Vessel Revascularization: Importance of Robust Study Design and Database Utilization. Hearts. 2024; 5(4):569-571. https://doi.org/10.3390/hearts5040042
Chicago/Turabian StyleNienaber, Christoph A., and Stephan Nienaber. 2024. "Long Time No See! Revisiting Single-Vessel Revascularization: Importance of Robust Study Design and Database Utilization" Hearts 5, no. 4: 569-571. https://doi.org/10.3390/hearts5040042
APA StyleNienaber, C. A., & Nienaber, S. (2024). Long Time No See! Revisiting Single-Vessel Revascularization: Importance of Robust Study Design and Database Utilization. Hearts, 5(4), 569-571. https://doi.org/10.3390/hearts5040042